Divestment signals pharma focus for Mochida
This article was originally published in Scrip
Executive Summary
Mochida has cut its holding in a Japanese medical equipment joint venture with Siemens to just 10%, in a renewed sign that the mid-sized firm will focus on its core drugs business.